Want to see LCTC full AI Analyst Report?
LCTC Stock Chart & Stats
$3.87
-$0.37(-9.85%)
At close: 4:00 PM EDT
$3.87
-$0.37(-9.85%)
Day’s Range― - ―
52-Week Range$1.75 - $4.25
Previous CloseN/A
Volume700.00
Average Volume (3M)1.46K
Market Cap
$11.40M
Enterprise Value$9.55
Total Cash (Recent Filing)$908.21K
Total Debt (Recent Filing)$2.28M
Price to Earnings (P/E)―
Beta0.23
Next Earnings
Nov 05, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.75
Shares Outstanding2,752,616
10 Day Avg. Volume355
30 Day Avg. Volume1,461
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)1.60
Price to Sales (P/S)0.73
P/FCF Ratio-14.26
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue Rebound And Gross MarginThe sharp TTM revenue rebound indicates renewed demand for Lifeloc’s breath alcohol testing products, while improved gross margin shows better economics on sales. If maintained, this combination can provide a stronger base for scaling the business and funding future product development.
Conservative LeverageVery low leverage reduces debt-related financial pressure and leaves more flexibility to support operations, product investment, or customer programs. The substantial improvement from prior years also lowers balance-sheet risk over the next several quarters, provided losses do not materially erode equity.
Improved Operating And Free Cash FlowPositive operating and free cash flow represent a meaningful recovery from negative free cash flow in 2023–2025. Sustained cash generation would improve self-funding capacity, reduce reliance on external capital, and support maintenance of the installed breathalyzer base and product pipeline.
Bears Say
Persistent UnprofitabilityOngoing losses show that the recent revenue recovery has not yet translated into durable operating profitability. Negative EBIT and EBITDA limit internally generated resources, weaken resilience if demand softens, and make execution on growth initiatives more dependent on achieving further margin improvement.
Volatile Cash-flow ConsistencyRecent positive cash flow is encouraging, but the multi-year volatility makes it difficult to treat current generation as a dependable recurring strength. Inconsistent cash conversion can complicate budgeting, constrain investment planning, and increase financial pressure if another weak period occurs.
Uneven Earnings PowerThe history of alternating profitability and losses indicates that earnings power has not yet become consistent. Deeply negative TTM return on equity further shows that the capital base is currently producing poor returns, limiting confidence that growth will reliably compound shareholder value.
Lifeloc Technologies News
LCTC FAQ
What was Lifeloc Technologies Inc’s price range in the past 12 months?
Lifeloc Technologies Inc lowest stock price was $1.75 and its highest was $4.25 in the past 12 months.
What is Lifeloc Technologies Inc’s market cap?
Lifeloc Technologies Inc’s market cap is $11.40M.
When is Lifeloc Technologies Inc’s upcoming earnings report date?
Lifeloc Technologies Inc’s upcoming earnings report date is Nov 05, 2026 which is in 36 days.
How were Lifeloc Technologies Inc’s earnings last quarter?
Lifeloc Technologies Inc released its earnings results on Aug 13, 2026. The company reported -$0.049 earnings per share for the quarter.
Is Lifeloc Technologies Inc overvalued?
According to Wall Street analysts Lifeloc Technologies Inc’s price is currently Overvalued.
Does Lifeloc Technologies Inc pay dividends?
Lifeloc Technologies Inc does not currently pay dividends.
What is Lifeloc Technologies Inc’s EPS estimate?
Lifeloc Technologies Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Lifeloc Technologies Inc have?
Lifeloc Technologies Inc has 2,752,616 shares outstanding.
What happened to Lifeloc Technologies Inc’s price movement after its last earnings report?
Lifeloc Technologies Inc reported an EPS of -$0.049 in its last earnings report. Following the earnings report the stock price went up 4.575%.
Which hedge fund is a major shareholder of Lifeloc Technologies Inc?
Currently, no hedge funds are holding shares in LCTC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Lifeloc Technologies Inc
Lifeloc Technologies, Inc. develops, manufactures, and markets portable hand-held and fixed station breathalyzers and related accessories for law enforcement, workplace, corrections, original equipment manufacturing, and consumer markets worldwide. It offers fuel-cell based breath alcohol testing equipment; and a line of supplies, accessories, services, and training to support customers alcohol testing programs. The company also develops and sells online drug and alcohol training and refresher courses. In addition, it engages in the ownership and rental of real property through existing commercial leases. Further, the company provides Sentinel zero tolerance alcohol screening station; R.A.D.A.R, a real-time alcohol detection and reporting product; and calibration products, as well as breath testing devices. Additionally, it offers EASYCAL automatic calibration station; Phoenix 6.0 evidential breath testers; Lifeloc; and SpinDx. The company was incorporated in 1983 and is headquartered in Wheat Ridge, Colorado. Lifeloc Technologies, Inc. is a subsidiary of EDCO Partners LLLP.
Technical Analysis
Research Frontiers
―
CPS Technologies
―
Interlink Electronics
―
SOBR Safe
―
KULR Technology Group
―